Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Zarate

Showing results (31-40 of 707) with videos related to

Pageof 71
Sort By:
Bipolar Disorders|June 5, 2003
Combination treatment in bipolar disorder: a review of controlled trialsCarlos A Zarate, Jorge A Quiroz
Molecular Psychiatry|May 3, 2002
Molecular and cellular mechanisms underlying mood stabilization in bipolar disorder: implications for the development of improved therapeuticsH K Manji, C A Zarate
Pharmacology, Biochemistry, and Behavior|January 21, 2020
Electrophysiological biomarkers of antidepressant response to ketamine in treatment-resistant depression: Gamma power and long-term potentiationJessica R Gilbert, Carlos A Zarate
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|March 22, 2018
Using Neuroimaging to Decipher the Mechanism of Action of Ketamine: A Pathway to Novel Therapeutics?Allison C Nugent, Carlos A Zarate
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|September 27, 2015
Ketamine for depression: evidence, challenges and promiseCarlos A Zarate, Mark J Niciu
Biological Psychiatry|June 9, 2015
Potential Pathways Involved in the Rapid Antidepressant Effects of Nitrous OxideCarlos A Zarate, Rodrigo Machado-Vieira
Bipolar Disorders|December 13, 2006
Pharmacological treatment of psychiatric comorbidity in bipolar disorder: a review of controlled trialsJaskaran B Singh, Carlos A Zarate
The Mount Sinai Journal of Medicine, New York|August 16, 2008
Bipolar disorder: candidate drug targetsCarlos A Zarate, Husseini K Manji
The Journal of Clinical Psychiatry|September 12, 2013
Pulsed intravenous administration of scopolamine produces rapid antidepressant effects and modest side effectsMaura L Furey, Carlos A Zarate
Experimental Neurology|February 23, 2008
The role of AMPA receptor modulation in the treatment of neuropsychiatric diseasesCarlos A Zarate, Husseini K Manji
Pageof 71

Showing results (31-40 of 707) with videos related to

Sort By:
Pageof 71
Bipolar Disorders|June 5, 2003
Combination treatment in bipolar disorder: a review of controlled trialsCarlos A Zarate, Jorge A Quiroz
Molecular Psychiatry|May 3, 2002
Molecular and cellular mechanisms underlying mood stabilization in bipolar disorder: implications for the development of improved therapeuticsH K Manji, C A Zarate
Pharmacology, Biochemistry, and Behavior|January 21, 2020
Electrophysiological biomarkers of antidepressant response to ketamine in treatment-resistant depression: Gamma power and long-term potentiationJessica R Gilbert, Carlos A Zarate
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|March 22, 2018
Using Neuroimaging to Decipher the Mechanism of Action of Ketamine: A Pathway to Novel Therapeutics?Allison C Nugent, Carlos A Zarate
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|September 27, 2015
Ketamine for depression: evidence, challenges and promiseCarlos A Zarate, Mark J Niciu
Biological Psychiatry|June 9, 2015
Potential Pathways Involved in the Rapid Antidepressant Effects of Nitrous OxideCarlos A Zarate, Rodrigo Machado-Vieira
Bipolar Disorders|December 13, 2006
Pharmacological treatment of psychiatric comorbidity in bipolar disorder: a review of controlled trialsJaskaran B Singh, Carlos A Zarate
The Mount Sinai Journal of Medicine, New York|August 16, 2008
Bipolar disorder: candidate drug targetsCarlos A Zarate, Husseini K Manji
The Journal of Clinical Psychiatry|September 12, 2013
Pulsed intravenous administration of scopolamine produces rapid antidepressant effects and modest side effectsMaura L Furey, Carlos A Zarate
Experimental Neurology|February 23, 2008
The role of AMPA receptor modulation in the treatment of neuropsychiatric diseasesCarlos A Zarate, Husseini K Manji
Pageof 71